PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32517647-0	2020	Tolfenamic acid inhibits GSK-3beta and PP2A mediated tau hyperphosphorylation in Alzheimer"s disease models.	tolfenamic acid	0-15	protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform	Mus musculus	39-43	
32517647-7	2020	Tolfenamic acid decreased the expression of hyperphosphorylated tau in the brain by inhibiting GSK-3beta activity, decreasing phosphorylated PP2A (Tyr307), and enhancing PP2A activity.	tolfenamic acid	0-15	protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform	Mus musculus	141-145	
32517647-7	2020	Tolfenamic acid decreased the expression of hyperphosphorylated tau in the brain by inhibiting GSK-3beta activity, decreasing phosphorylated PP2A (Tyr307), and enhancing PP2A activity.	tolfenamic acid	0-15	protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform	Mus musculus	170-174	
32517647-8	2020	Tolfenamic acid also increased wortmannin (WT) and GF-109203X (GFX) induced phosphorylation of GSK-3beta (Ser9) and prevented OA-induced downregulation of PP2A activity in PC12 cells.	tolfenamic acid	0-15	protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform	Mus musculus	155-159	
32517647-9	2020	Altogether, these results show that tolfenamic acid not only decreased SP1/CDK5-mediated tau phosphorylation, but also inhibited GSK-3beta and PP2A-mediated tau hyperphosphorylation in AD models.	tolfenamic acid	36-51	protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform	Mus musculus	143-147